CCR2 and myeloproliferative neoplasm: Finally, the observation that, during the longitudinal follow-up of a MPN patient, the increase in CCR2+ cells paralleled disease progression into post-PV MF provides the proof-of-concept of the potential impact in the clinical setting of our findings.